1. Home
  2. Author
  3. Crouzier L

Crouzier L

References (2)

Title : Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the s (1) chaperone protein - Garcia-Pupo_2024_Acta.Pharm.Sin.B_14_4345
Author(s) : Garcia-Pupo L , Crouzier L , Bencomo-Martinez A , Meunier J , Morilleau A , Delprat B , Carrazana MS , Menendez Soto Del Valle R , Maurice T , Rodriguez-Tanty C
Ref : Acta Pharm Sin B , 14 :4345 , 2024
Abstract :
PubMedSearch : Garcia-Pupo_2024_Acta.Pharm.Sin.B_14_4345
PubMedID: 39525570

Title : The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease - Carles_2024_CNS.Neurosci.Ther_30_e14814
Author(s) : Carles A , Hoffmann M , Scheiner M , Crouzier L , Bertrand-Gaday C , Chatonnet A , Decker M , Maurice T
Ref : CNS Neurosci Ther , 30 :e14814 , 2024
Abstract :
PubMedSearch : Carles_2024_CNS.Neurosci.Ther_30_e14814
PubMedID: 38887858